Assembly Biosciences ASMB Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Assembly Biosciences's investment proceeds?
- Assembly Biosciences (ASMB) reported investment proceeds of $57.6M in Q1 2026.
- How has Assembly Biosciences's investment proceeds changed year-over-year?
- Assembly Biosciences's investment proceeds increased by 117.9% year-over-year, from $26.43M to $57.6M.
- What is the long-term trend for Assembly Biosciences's investment proceeds?
- Over 3 years (2022 to 2025), Assembly Biosciences's investment proceeds has grown at a 59.3% compound annual growth rate (CAGR), from $28.83M to $116.43M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.